However, due to the complexity of protein kinase signaling networks, modifying the activity of one kinase in purpose may yield broad outcomes from various respects in distinct neurodegenerative diseases, possibly resulting from interferences of the dynamics of its interacting kinases, therefore disruption of physiological processes by such inhibitor may also result in potential side effects.641. This evidence concerns the gene WEE1 and neurodegenerative disease.